Annual Report & ACCOUNTS for the year ended 30 June 2014

HYR 2014


The Group's ultimate Parent Company is Dechra Pharmaceuticals PLC. A listing of all principal subsidiaries is shown in note (xii).

Transactions with Key Management Personnel

The details of the remuneration, Long Term Incentive Plans, shareholdings, share options and pension entitlements of individual Directors are included in the Directors' Remuneration Report. The remuneration of key management is disclosed in note 7.